Need help finding what you are looking for?
Contact Us
PUBLISHER: BCC Research | PRODUCT CODE: 1465618
PUBLISHER: BCC Research | PRODUCT CODE: 1465618
Exosome Diagnostics, Therapeutics and Research Tools: Global Markets
PUBLISHED:
PAGES: 101 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
The global market for exosome diagnostics, therapeutics and research tools is estimated to increase from $227.5 million in 2023 to reach $1.3 billion by 2028, at a compound annual growth rate (CAGR) of 42.2% from 2023 through 2028.
The global market for research tools and reagents in exosome diagnostics, therapeutics and research tools is estimated to increase from $137.2 million in 2023 to reach $352.7 million by 2028, at a CAGR of 20.8% from 2023 through 2028.
The global market for diagnostics and monitoring in exosome diagnostics, therapeutics and research tools is estimated to increase from $90.3 million in 2023 to reach $654.3 million by 2028, at a CAGR of 48.6% from 2023 through 2028.
Report Scope
This report aims to provide a comprehensive study of the global market for exosome diagnostic, therapeutic, and research tools, both in terms of quantitative and qualitative data, to help readers develop business/growth strategies, assess the market landscape, analyze their position in the current marketplace, and make informed business decisions regarding exosome products. BCC Research estimates market data for 2022 (the base year) and forecasts values for 2023 through 2028.
The scope of this study is global and covers exosome products and research tools used in the healthcare industry only. Exosome products and research tools used in other sectors, such as skincare and beauty, are beyond the scope of this report.
Report Includes
- 14 data tables and 77 additional tables
- Analysis of the global markets and global trends for exosome diagnostics and therapeutics, with revenue data for 2021-2022, estimates for 2023, forecasts for 2024, and projected CAGRs through 2028
- Estimate of the current market size and revenue growth prospects, along with a market share analysis based on product, application, end user and region
- Facts and figures pertaining to the market drivers, opportunities and restraints, and the impacts of macroeconomic variables
- Discussion of emerging technologies, regulations and R&D efforts
- Evaluation of new commercial opportunities in the diagnostics, therapeutics and research tools markets, and an assessment of trends, products and assay developments
- Insight into the use of exosome proteins and nucleic acids as diagnostic biomarkers and their impact on the microRNA, liquid biopsy and stem cell research industry
- Analysis of relevant patents related to exosome diagnostics and therapeutics in the U.S., Europe and Japan
- Overview of sustainability trends and ESG developments, including consumer attitudes, companies' ESG score rankings and their ESG practices
- Analysis of the competitive landscape, including companies' market shares, business segments, financials and product portfolios, as well as recent M&A activity and a venture funding outlook
- Company profiles of major players within the industry, including Bio-Techne, Exosomics S.p.A., and System Biosciences LLC.
Product Code: BIO149E
Table of Contents
Chapter 1 Executive Summary
- Market Outlook
- Scope of Report
- Market Summary
Chapter 2 Market Overview
- Exosome Basics
- Exosome Biogenesis and Processing
- Exosome Function and Physiology
- Intracellular Communication
- Facilitation of the Immune Response
- Tissue Regeneration
- Bioinformatic Databases for Exosome Research and Product Development
- ExoCarta
- Vesiclepedia
- EVpedia
Chapter 3 Market Dynamics
- Overview
- Market Drivers
- Increasing Investment in Biomedical Research
- Trend Towards Precision Medicine
- Technological Advancements in Exosome Research Tools
- Restraints
- Evolving Regulatory Landscape
- Lack of Well-Characterized Exosome Standards
- Opportunities
- Growing Popularity in Liquid Biopsy
- Benefits Over Stem Cell Therapy
- Challenges
- Funding Issues
Chapter 4 Regulatory Landscape
- U.S.
- Exosome Therapeutics
- Exosome Clinical Assays Development and Marketing
Chapter 5 Emerging Technologies and Developments
- Emerging Technologies
- Engineered Exosomes
- Microfluidic Technology
- Exosome Research Services
- Exosome Based Liquid Biopsy Tests
- Clinical Trial Analysis
- Overview
- By Phases
- By Funder Type
- By Disease Type
- By Country
- Pipeline Analysis
Chapter 6 Market Segmentation Analysis
- Segmental Breakdown
- Market Analysis by Application Type
- Diagnostics and Monitoring
- Evaluation of the Diagnostics and Monitoring Market
- Cancer
- CNS Disorders and Neurodegeneration Diseases
- Organ Transplantation
- Cardiovascular Diseases
- Others
- Diagnostics and Monitoring Market Revenue
- Exosome Therapeutics
- Potential Therapeutic Applications
- Evaluation of the Current and Potential Therapeutics Market
- Key Target Indications
- Research Tools and Regents
- Research Tools and Reagents Market Revenue
- Geographic Breakdown
- North America
- Europe
- Asia-Pacific
- Rest of the World (RoW)
Chapter 7 Competitive Intelligence
- Overview
- Exosome-Based Clinical Diagnostics Market
- Market Participants in the Exosome-Based Clinical Diagnostics Market
- Exosome-Based Therapeutics Market
- Market Participants in the Exosome-Based Therapeutics Market
- Exosome Research Tools and Reagents Market
- Market Participants in the Exosome Research Tools and Reagents Market
- Key Strategies
- Opportunities and Challenges in the Exosome Market
Chapter 8 Appendix
- Methodology
- Sources/References
- Acronyms
- Company Profiles
- ACOUSORT AB
- AEGLE THERAPEUTICS
- AETHLON MEDICAL INC.
- ARUNA BIO INC.
- BIO-TECHNE
- CAPRICOR THERAPEUTICS INC.
- CARIS LIFE SCIENCES
- DIRECT BIOLOGICS LLC
- EXOSOMICS SPA
- EVOX THERAPEUTICS LTD.
- KIMERA LABS
- LONZA
- MIR SCIENTIFIC
- NANO MED
- NANOSOMIX
- RION
- SYSTEM BIOSCIENCES LLC
Product Code: BIO149E
List of Tables
- Summary Table : Global Market for Exosome Diagnostics, Therapeutics and Research Tools, by Application, Through 2028
- Table 1 : Steps in Exosome Biogenesis and Processing
- Table 2 : Comparison of Databases for Exosome Studies
- Table 3 : Key Properties of CTC vs. cfDNA vs. Exosomes
- Table 4 : FDA Drug Approval Process
- Table 5 : Multiple Paths to Market for Biomarker Tests
- Table 6 : Phase 1 Above Active and Completed Clinical Trials for Potential Exosome Therapeutic Candidates
- Table 7 : Why Exosomes as Biomarkers
- Table 8 : Examples of Exosomal Proteins for Clinical Diagnostic Applications
- Table 9 : Examples of Exosomal miRNA for Clinical Diagnostic Applications
- Table 10 : Exosome-Based Commercial Clinical Assays for Prostate Cancer
- Table 11 : Selected Exosome-Based Clinical Assays that Are Currently Undergoing Clinical Validation
- Table 12 : Global Market for Exosome Diagnostics and Monitoring, Through 2028
- Table 13 : Examples of Engineering Exosome for Cargo Delivery
- Table 14 : Intrinsic Therapeutic Activity of Exosomes
- Table 15 : Comparison of Cell and Exosome Therapies
- Table 16 : Global Market for Exosome Therapeutics, Through 2028
- Table 17 : Exosome Clinical Studies for ARDS
- Table 18 : Exosome Clinical Studies for RP
- Table 19 : Exosome Clinical Studies for Skin Conditions
- Table 20 : Exosome Clinical Studies for Autoimmune and Inflammatory Diseases
- Table 21 : Exosome Clinical Studies for Other Conditions
- Table 22 : Main Steps in the Exosome Research Approach
- Table 23 : Methods for Exosome Isolation
- Table 24 : Comparison of Exosome Isolation and Purification Methods
- Table 25 : Examples of Commercially Available Exosome Isolation and Purification Research Tools
- Table 26 : Methods for Exosome Detection and Analysis
- Table 27 : Important Antibodies for Exosome Research
- Table 28 : Examples of Commercially Available Exosome Engineering Tools
- Table 29 : Global Market for Exosome Research Tools and Reagents, Through 2028
- Table 30 : Global Market for Exosome Diagnostics, Therapeutics and Research Tools and Reagents, by Region, Through 2028
- Table 31 : North American Market for Exosome Diagnostics, Therapeutics and Research Tools and Reagents, by Application, Through 2028
- Table 32 : European Market for Exosome Diagnostics, Therapeutics and Research Tools and Reagents, by Application, Through 2028
- Table 33 : Asia-Pacific Market for Exosome Diagnostics, Therapeutics and Research Tools and Reagents, Through 2028
- Table 34 : RoW Market for Exosome Diagnostics, Therapeutics and Research Tools and Reagents, Through 2028
- Table 35 : Key Market Participants in Exosome-based Clinical Assays Market
- Table 36 : Key Market Participants in Exosome-based Therapeutics Sector
- Table 37 : Main Market Participants in Exosome Research Tools and Reagents
- Table 38 : Selected Collaborations/Partnerships in the Exosome Market
- Table 39 : Glossary of Terms Used in Exosome Diagnostics and Therapeutics: Global Markets
- Table 40 : AcouSort AB: Company Snapshot
- Table 41 : AcouSort AB: Financial Performance, FY 2021 and 2022
- Table 42 : AcouSort AB: Product Portfolio
- Table 43 : AcouSort AB: News/Key Developments, 2022
- Table 44 : Aegle Therapeutics: Company Snapshot
- Table 45 : Aegle Therapeutics: Product Portfolio
- Table 46 : Aethlon Medical Inc.: Company Snapshot
- Table 47 : Aethlon Medical Inc.: Financial Performance, FY 2022 and 2023
- Table 48 : Aethlon Medical Inc.: Product Portfolio
- Table 49 : Aethlon Medical Inc.: News/Key Developments, 2022 and 2023
- Table 50 : Aruna Bio Inc.: Company Snapshot
- Table 51 : Aruna Bio Inc.: Product Portfolio
- Table 52 : Aruna Bio Inc.: News/Key Developments, 2024
- Table 53 : Bio-Techne: Company Snapshot
- Table 54 : Bio-Techne: Financial Performance, FY 2022 and 2023
- Table 55 : Bio-Techne: Product Portfolio
- Table 56 : Bio-Techne: News/Key Developments, 2022 and 2023
- Table 57 : Capricor Therapeutics Inc.: Company Snapshot
- Table 58 : Capricor Therapeutics Inc.: Financial Performance, FY 2022 and 2023
- Table 59 : Capricor Therapeutics Inc.: Product Portfolio
- Table 60 : Capricor Therapeutics Inc.: News/Key Developments, 2024
- Table 61 : Caris Life Sciences: Company Snapshot
- Table 62 : Caris Life Sciences: Product Portfolio
- Table 63 : Caris Life Sciences: News/Key Developments, 2022
- Table 64 : Direct Biologics LLC: Company Snapshot
- Table 65 : Direct Biologics LLC: Product Portfolio
- Table 66 : Direct Biologics LLC: News/Key Developments, 2022 and 2023
- Table 67 : Exosomics SPA: Company Snapshot
- Table 68 : Exosomics SPA: Product Portfolio
- Table 69 : EVOX Therapeutics Ltd.: Company Snapshot
- Table 70 : Evox Therapeutics Ltd.: Product Portfolio
- Table 71 : Evox Therapeutics Ltd.: News/Key Developments, 2021-2023
- Table 72 : Kimera Labs: Company Snapshot
- Table 73 : Kimera Labs: Product Portfolio
- Table 74 : Kimera Labs: News/Key Developments, 2023
- Table 75 : Lonza: Company Snapshot
- Table 76 : Lonza: Financial Performance, FY 2022 and 2023
- Table 77 : Lonza: Product Portfolio
- Table 78 : Lonza: News/Key Developments, 2021
- Table 79 : miR Scientific: Company Snapshot
- Table 80 : miR Scientific: Product Portfolio
- Table 81 : miR Scientific: News/Key Developments, 2022 and 2023
- Table 82 : Nano Med: Company Snapshot
- Table 83 : Nano Med: Product Portfolio
- Table 84 : NanoSomiX: Company Snapshot
- Table 85 : NanoSomiX: Product Portfolio
- Table 86 : Rion: Company Snapshot
- Table 87 : Rion: Product Portfolio
- Table 88 : Rion: News/Key Developments, 2023 and 2024
- Table 89 : System Biosciences LLC: Company Snapshot
- Table 90 : System Biosciences LLC: Product Portfolio
List of Figures
- Summary Figure : Global Market for Exosome Diagnostics, Therapeutics and Research Tools, by Application, 2021-2028
- Figure 1 : Key Cellular Process under Investigation for Potential Role of Exosomes
- Figure 2 : Market Dynamics of Exosome Diagnostics, Therapeutics and Research Tools
- Figure 3 : PubMed Article Count: "Exosome," 2017-2023
- Figure 4 : Interest Over Time on Google Trends: "Exosome," 2017-2023
- Figure 5 : Exosomes: Scalable Production
- Figure 6 : Emerging Technologies in the Exosome Market
- Figure 7 : Exosome Clinical Studies, by Phase, as of January 2024
- Figure 8 : Exosome Clinical Studies, by Funder Type, January 2024
- Figure 9 : Exosome Clinical Studies, by Disease Type, January 2024
- Figure 10 : Exosome Clinical Studies, by Country, January 2024
- Figure 11 : Potential Clinical Applications of Exosome-based Assays
- Figure 12 : Global Market for Exosome Diagnostics and Monitoring, 2021-2028
- Figure 13 : Global Market for Exosome Therapeutics, 2021-2028
- Figure 14 : Exosome Research Process and Product Uses
- Figure 15 : Global Market for Exosome Research Tools and Reagents, 2021-2028
- Figure 16 : Global Market Shares of Exosome Diagnostics, Therapeutics and Research Tools and Reagents, by Region, 2022
- Figure 17 : Investment in Grants for Biomedical Research, by Region, 2020
- Figure 18 : Opportunities and Challenges in the Exosome Market
- Figure 19 : Bio-Techne: Revenue Share, by Business Unit, FY 2023
- Figure 20 : Bio-Techne: Revenue Share, by Country/Region, FY 2023
- Figure 21 : Lonza: Revenue Share, by Business Unit, FY 2023
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.